Arbutus Biopharma Cp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ABUS | ANL | FULC | ||
Company | Arbutus Biopharma Cp | Adlai Nortye Ltd American Depositary Shares | Fulcrum Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 2.71 | 13.50 | 7.90 | ||
High | 2.85 | 13.79 | 8.05 | ||
Low | 2.70 | 13.40 | 7.70 | ||
Last | 2.71 | 13.78 | 7.75 | ||
Change | +0.03 | +0.76 | +0.10 | ||
% Change | +1.12% | +5.84% | +1.31% | ||
Volume | 683,600 | 3,200 | 207,600 | ||
20-Day Average Volume | 926,155 | 19,410 | 446,090 | ||
Previous Close | 2.68 | 13.02 | 7.65 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 2.82 | 12.42 | 7.46 | ||
20-Day Raw Stochastic | 14.41% | 56.37% | 51.67% | ||
20-Day Relative Strength | 48.49% | 59.18% | 45.04% | ||
Weighted Alpha | +12.05 | +9.75 | +113.78 | ||
Today's Opinion | 64% Buy | N/A | 24% Buy | ||
Previous Opinion | 64% Buy | N/A | 24% Buy | ||
Last Month's Opinion | 88% Buy | N/A | 56% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -0.73% since 04/26/24 | +0.22% since 04/26/24 | +8.54% since 04/26/24 | ||
Low | 2.63 on 05/02/24 | 11.81 on 05/02/24 | 6.97 on 04/29/24 | ||
High | 2.85 on 05/03/24 | 14.90 on 04/29/24 | 8.05 on 05/03/24 | ||
1-Month | |||||
%Chg | -7.19% since 04/03/24 | +41.48% since 04/03/24 | -15.12% since 04/03/24 | ||
Low | 2.63 on 05/02/24 | 7.65 on 04/05/24 | 6.67 on 04/19/24 | ||
High | 3.29 on 04/05/24 | 17.48 on 04/08/24 | 9.60 on 04/04/24 | ||
3-Month | |||||
%Chg | +13.87% since 02/02/24 | +50.93% since 01/29/24 | unch since 02/02/24 | ||
Low | 2.30 on 04/03/24 | 7.11 on 02/22/24 | 6.67 on 04/19/24 | ||
High | 3.29 on 04/05/24 | 17.48 on 04/08/24 | 13.70 on 03/06/24 | ||
6-Month | |||||
%Chg | +41.15% since 11/03/23 | +61.93% since 11/03/23 | +99.23% since 11/03/23 | ||
Low | 1.70 on 11/13/23 | 7.11 on 02/22/24 | 3.24 on 11/10/23 | ||
High | 3.29 on 04/05/24 | 17.48 on 04/08/24 | 13.70 on 03/06/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 486,423 | 508,482 | 481,693 | ||
Shares Outstanding, K | 179,492 | 36,900 | 62,154 | ||
Annual Sales | 18,140,000 | 5,000,000 | 2,810,000 | ||
Annual Net Income | -72,850,000 | -104,871,000 | -97,340,000 | ||
Last Quarter Sales | 2,150,000 | 0 | 870,000 | ||
Last Quarter Net Income | -19,310,000 | -63,397,000 | -24,760,000 | ||
60-Month Beta | 2.05 | N/A | 2.35 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.12 on 02/29/24 | N/A | -0.40 on 02/27/24 | ||
Latest Earnings Date | 05/02/24 | N/A | 05/20/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |